ResearcherDonghua UniversityNo recent work listed

Guizhi Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-0122-7276; OpenAlex author ID A5081629936. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Redox-Responsive Dendrimer Nanogels Enable Ultrasound-Enhanced Chemoimmunotherapy of Pancreatic Cancer via Endoplasmic Reticulum Stress Amplification and Macro… Co-author DOI 10.1002/advs.202301759 ↗
Integrated analysis of tumor differentiation genes in pancreatic adenocarcinoma. First author DOI 10.1371/journal.pone.0193427 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ting Xi · 1 shared paper, 2018 · strength 0.17
- Paper Integrated analysis of tumor differentiation genes in pancreatic adenocarcinoma. DOI 10.1371/journal.pone.0193427 ↗
Xiangyang Shi · 1 shared paper, 2023 · strength 0.17
- Paper Redox-Responsive Dendrimer Nanogels Enable Ultrasound-Enhanced Chemoimmunotherapy of Pancreatic Cancer via Endoplasmic … DOI 10.1002/advs.202301759 ↗
Han Wang · 1 shared paper, 2023 · strength 0.17
- Paper Redox-Responsive Dendrimer Nanogels Enable Ultrasound-Enhanced Chemoimmunotherapy of Pancreatic Cancer via Endoplasmic … DOI 10.1002/advs.202301759 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.